Albemarle Corporation
Financials
Valuation Metrics
Albemarle Corporation's Market Cap is $14.00B. At end of 2025 it was $16.65B. Ranked #758 of 3,111 in US market (top 24%), #523 of 1,666 on NYSE (top 31%), #42 of 173 in Materials (top 24%) by Market Cap.
Investment Metrics(as of 2026-08-03)
| Metric | Value | Rank |
|---|---|---|
| Size | ||
| Market Cap | $14.00B | US#758/3,111 Sec#42/173 |
| Revenue | $5.49B | US#848/3,111 Sec#57/173 |
| Net Income | $-233M | US—/3,111 Sec—/173 |
| Total Assets | $15.14B | US#752/3,111 Sec#43/173 |
| Net Assets | $9.85B | US#427/3,111 Sec#29/173 |
| Employees | 7,800 | US#684/3,111 Sec#31/173 |
| Value | ||
| P/B | 1.42x | US#746/3,111 Sec#43/173 |
| P/S | 2.55x | US#1,547/3,111 Sec#94/173 |
| EV/EBITDA | 19.80x | US#1,842/3,111 Sec#123/173 |
| FCF Yield | 4.12% | US#1,496/3,111 Sec#72/173 |
| Profitability | ||
| ROE | -2.36% | US#2,237/3,111 Sec#125/173 |
| ROA | -1.54% | US#2,350/3,111 Sec#125/173 |
| Op. Margin | 5.55% | US#2,015/3,111 Sec#118/173 |
| Revenue Growth | 32.67% | US#464/3,111 Sec#53/173 |
| Earnings Growth | 671.72% | US#71/3,111 Sec#8/173 |
| Financial Health | ||
| Debt Ratio | 51.08% | US#591/3,111 Sec#49/173 |
| Total Debt | $1.88B | US#1,194/3,111 Sec#62/173 |
| FCF | $577M | US#807/3,111 Sec#40/173 |
| Cash | $1.09B | US#650/3,111 Sec#36/173 |
| Current Ratio | 2.07x | US#1,216/3,111 Sec#94/173 |
| Net Debt/EBITDA | 1.06x | US#1,016/3,111 Sec#72/173 |
| Dividend | ||
| Div. Yield | 1.36% | US#1,146/3,111 Sec#55/173 |
| Div. Growth | 0.90% | US#1,148/3,111 Sec#71/173 |
| Performance | ||
| 1Y Return | 76.31% | US#432/3,111 Sec#37/173 |
| 1M Return | -12.43% | US#2,640/3,111 Sec#150/173 |
| From 52W High | -46.29% | US#2,671/3,111 Sec#139/173 |
| 1Y MDD | -47.52% | US#2,299/3,111 Sec#129/173 |
| Trading | ||
| Volume | 1,746,162 shares | US#1,057/3,111 Sec#74/173 |
| Trading Value | $206M | US#564/3,111 Sec#30/173 |
| Per Share | ||
| EPS | $-4.34 | US—/3,111 Sec—/173 |
| BPS | $81.00 | US#174/3,111 Sec#9/173 |
Company Info
Albemarle Corporation provides energy storage solutions worldwide. It operates through three segments: Energy Storage, Specialties, and Ketjen. The Energy Storage segment offers lithium compounds, including lithium carbonate, lithium hydroxide, and lithium chloride for use in lithium batteries used in consumer electronics and electric vehicles, power grids and solar panels, high performance greases, specialty glass used in consumer appliances and electronics. The Specialties segment provides bromine and highly specialized lithium solutions for various industries, such as energy, mobility, connectivity, and health comprising fire safety compounds; bromine-based specialty chemicals products, including elemental bromine, alkyl bromides, inorganic bromides, brominated powdered activated carbon, and various bromine fine chemicals; lithium specialties, such as butyllithium and lithium aluminum hydride; cesium products for the chemical and pharmaceutical industries; and zirconium, barium, and titanium products for pyrotechnical applications that include airbag initiators. This segment also provides organic synthesis processes in the areas of steroid chemistry and vitamins, and various life science applications, as well as intermediates in the pharmaceutical industry; technical services, including handling and use of reactive lithium products; and recycling services for lithium-containing by-products. The Ketjen segment offers clean fuels technologies, including hydroprocessing catalysts together with isomerization and akylation catalysts; fluidized catalytic cracking catalysts and additives; and performance catalyst solutions comprising organometallics and curatives. It serves grid storage, automotive, aerospace, conventional energy, electronics, construction, agriculture and food, pharmaceuticals and medical device industries. Albemarle Corporation was founded in 1887 and is headquartered in Charlotte, North Carolina.